express scripts glp 1 coverage expands Patient Assurance Program to drive affordability and access to GLP-1s Affordable GLP-1 medications for seniors
Description
Immunology 172 (3), 451468
During follow-up, 1,670 subjects in the GLP-1 cohort and 1,886 in the DPP-4 cohort developed epilepsy, or 2.35% vs 2.41%
Note: Weight loss results from Contrave and Zepbound will vary from person to person due to factors including nutrition, physical activity, environment, medical history, and other medications
Cons of GLP-1s: Potential side effects, high cost, and the need for continuous use
The incurable disease usually gets worse over time and can become a permanent disability, Dayan notes
(Reasons 2-4, at rates described in 5, in the manner described in 7.) Dont make this mistake
